Tocqueville Asset Management’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-12,150
Closed -$1.22M 1037
2015
Q1
$1.22M Buy
12,150
+1,450
+14% +$96.6K 0.01% 552
2014
Q4
$562K Buy
+10,700
New +$314K 0.01% 684
2014
Q3
Sell
-6,700
Closed -$149K 1526
2014
Q2
$149K Buy
6,700
+200
+3% +$4.38K ﹤0.01% 1046
2014
Q1
$200K Buy
+6,500
New +$175K ﹤0.01% 792

Tocqueville Asset Management's ASPX Position: Q2 2015 in Review

Tocqueville Asset Management sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 12,150 shares — an estimated $1.22M sold.

Tocqueville Asset Management first reported a position in ASPX in Q1 2014 and held it in 4 quarters. The position peaked at $1.22M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Tocqueville Asset Management reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Tocqueville Asset Management sold 12,150 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $1.22M.
  • Tocqueville Asset Management first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 4 quarters.
  • Tocqueville Asset Management's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.22M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Tocqueville Asset Management's 13F filing for Q2 2015, filed 31 Jul 2015.